Cynosure to market Smartlipo MPX LaserBodySculpting Workstation in Korea

Broadening the reach of two of its flagship aesthetic laser products into the Asia Pacific region, Cynosure, Inc. (NASDAQ: CYNO) today announced that it has received approval to market the Smartlipo MPX(TM) LaserBodySculpting(SM) Workstation in Korea and the Affirm(TM) Anti-Aging Workstation in the People's Republic of China. Smartlipo MPX is the world's signature brand for precision body contouring; Affirm provides a complete skin rejuvenation solution that targets all layers of photodamaged and aged skin.

"These approvals for Smartlipo MPX and Affirm further our initiative to expand in the Asia Pacific region as part of our international growth strategy," said Cynosure President and Chief Executive Officer Michael Davin. "We believe that the increasing economic prosperity of the middle class in these countries is creating a vibrant base of aesthetically conscious consumers and a corresponding demand from practitioners eager to be trained on new procedures and techniques. By having already established a direct sales presence in China and Korea, we believe we are well positioned to capitalize on opportunities through new product introductions in these dynamic markets."

Smartlipo MPX and Affirm are among Cynosure's most popular workstations. Smartlipo MPX liquefies fat and tightens skin through tissue coagulation. The novel Smartlipo MPX platform incorporates the company's exclusive MultiPlex(TM) technology. MultiPlex combines the benefits of the 1064-nm and 1320-nm wavelengths in a single laser output, creating a blended thermal and photomechanical effect. The Smartlipo MPX workstation can be configured with the company's SmartSense with ThermaGuide, an intelligent energy delivery system equipped with a thermal sensing cannula for controlling temperatures in the subcutaneous areas of the body. This technology allows the practitioner to set temperature thresholds to achieve targeted, controlled energy delivery for a safe and optimal clinical endpoint.

The non-invasive Affirm Anti-Aging Workstation offers the benefits of wrinkle reduction, pigmentation and redness reduction, age spot treatment and overall facial rejuvenation. The MultiPlex technology-equipped Affirm enables the sequential emission of two wavelengths in one pulse from the same delivery system, helping to maximize comfort and achieve faster recovery time compared with single-wavelength technologies.

Affirm uses the 1440-nm Combined Apex Pulse(SM) technology to target superficial layers of photodamaged tissue, state-of-the-art Xenon Pulsed Light technology to enhance clinical outcomes associated with the treatment of redness and pigmentation, and 1320-nm MultiPlex technology to target deep layers of collagen structures for skin laxity and tightening.



The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Antidiabetic medication may also decrease blood vessel dysfunction associated with aging